News

Michael Kratsions, director of the Office of Science and Technology Policy, defined the key policy pillars in the White House ...
FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and pending with a focus on the development of therapeutics and potential cures ...
The poster can be viewed on FibroBiologics’ website here. “Our latest research demonstrates the potential of using an artificial ... Ph.D., Chief Scientific Officer of FibroBiologics. “Organoids are ...
Eupraxia's CEO, Dr. James Helliwell, will be presenting on May 5th, 2025, at 3:30pm ET at the Bloom Burton & Co. Healthcare Investor Conference being held at the Metro Toronto Convention Centre, and ...
Princeton Engineering Innovation Research Grants support bold new ideas tackling critical problems like antibiotic resistance ...
Hands on Experience: Sequence and annotate whole genomes of a variety of organisms using ... biotechnology graduates are employed at organizations such as Pfizer, Inc., Roswell Park Cancer Institute, ...
Health-based R&D accounted for 12% of all university research spending in 2001 and almost 20% of all university researchers were engaged in biomedical science ... biotechnology R&D (see Box 3 ...
In April 2025, our partner Jazz announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of ...
The term 'health biotechnology' evokes images of ... The analysis is based on the use of the Thomson ISI Science Citation Index Expanded database (SCI Expanded), which includes papers from more ...
Nonprofit research institute brings internship program to the Wiregrass to inspire the future of biotechnology careers.